Column Group Opportunity III, LP

13D and 13G Filings

13D/G filings
13D on 1 security
Location
San Francisco, CA
CIK
0001931825
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
Tenaya Therapeutics, Inc. 13D/A
TNYA · 87990A106
21.6% 11/16/2026
Event 9/30/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.